Yingli R. Wu
Key Laboratory Of Cell Differentiation And Apoptosis Of The Chinese Ministry Of Education
Shanghai, 201318, China
Shanghai, 201318, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Ubiquitin-specific protease 48: Molecular mechanisms, pathophysiological roles and therapeutic potential.
Journal: Biochemical and biophysical research communications
Published: May 15, 2026
USP2 in cancer: a double-edged sword and therapeutic target.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: May 11, 2026
Targeting USP2 induces degradation of PML-RARα with or without drug-resistant mutations in acute promyelocytic leukemia.
Journal: Acta biochimica et biophysica Sinica
Published: December 25, 2025
A degradable multi-metal-chelating stealth nanoplatform for dual ferroptosis/cuproptosis-enhanced metalloimmunotherapy in leukemia.
Journal: Journal of nanobiotechnology
Published: August 15, 2025
USP7 sustains hematopoietic stem cell homeostasis partially via PU.1 stabilization.
Journal: International journal of biological sciences
Published: August 13, 2025
Deubiquitinases in liver diseases: from mechanisms to targeted therapy.
Journal: Science China. Life sciences
Published: July 02, 2025
The diverse functions of ubiquitin-specific protease 47 and its role in diseases.
Journal: International journal of biological macromolecules
Published: June 25, 2025
USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ.
Journal: Cell death and differentiation
Published: April 07, 2025
CHK1-S, a splicing variant of CHK1, suppresses chronic myeloid leukemia.
Journal: Leukemia research
Published: March 30, 2025
Erratum: cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance.
Journal: American journal of cancer research
Published: March 25, 2025
Last Updated: 09/26/2026